公开(公告)号：US20240316180A1

公开(公告)日：2024-09-26

申请号：US18516257

申请日：2023-11-21

Applicant: Korea National Institute of Health

Inventor： Tae-young LEE ,  Seo Yeon KIM ,  Hyeran WON ,  You-Jin KIM ,  Dokeun KIM

IPC: A61K39/165 ,  A61P31/14 ,  A61P37/04 ,  C12N7/00 ,  G01N33/569

CPC classification number: A61K39/165 ,  A61P31/14 ,  A61P37/04 ,  C12N7/00 ,  G01N33/56983 ,  A61K2039/5254 ,  C12N2760/18721 ,  C12N2760/18722 ,  C12N2760/18734 ,  G01N2333/12

Abstract: The present invention relates to an attenuated mumps virus and a live vaccine comprising the same. The attenuated mumps virus vaccine of the present invention can be effectively used for additional vaccination to control the occurrence of breakthrough infection and the epidemic of mumps due to differences in genotypes of existing vaccine strains and epidemic strains and decreased immunity.